Rapid Micro Biosystems, Inc. (RPID)

NASDAQ: RPID · IEX Real-Time Price · USD
3.83
-0.15 (-3.77%)
Aug 15, 2022 4:30 PM EDT - Market closed
-3.77%
Market Cap 166.93M
Revenue (ttm) 22.40M
Net Income (ttm) -68.66M
Shares Out 43.59M
EPS (ttm) -2.28
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 26,586
Open 3.98
Previous Close 3.98
Day's Range 3.75 - 4.00
52-Week Range 2.49 - 23.00
Beta n/a
Analysts Buy
Price Target 15.81 (+312.8%)
Earnings Date Aug 25, 2022

About RPID

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) te... [Read more...]

Industry Wireless Telecommunication Services
IPO Date Jul 15, 2021
Employees 202
Stock Exchange NASDAQ
Ticker Symbol RPID
Full Company Profile

Financial Performance

In 2021, RPID's revenue was $23.23 million, an increase of 44.50% compared to the previous year's $16.08 million. Losses were -$73.52 million, 98.3% more than in 2020.

Financial Statements

Analyst Forecast

According to 10 analysts, the average rating for RPID stock is "Buy." The 12-month stock price forecast is 15.81, which is an increase of 312.79% from the latest price.

Price Target
$15.81
(312.79% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Lags Revenue Estimates

Rapid Micro Biosystems, Inc. (RPID) delivered earnings and revenue surprises of 11.43% and 24.21%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Rapid Micro Biosystems Provides Business Update and Reports Second Quarter 2022 Financial Results

Reports second quarter 2022 commercial revenue of $3.9 million

Rapid Micro Biosystems Announces Review of Strategic Alternatives to Maximize Shareholder Value

Rejects Unsolicited, Non-Binding Proposal from Kennedy Lewis Investment Management

Rapid Micro Biosystems to Announce Second Quarter 2022 Financial Results on August 12, 2022

LOWELL, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutio...

Rapid Micro Biosystems Confirms Receipt of Unsolicited, Non-Binding Proposal from Kennedy Lewis Investment Management

Shareholders Do Not Need to Take Action at This Time Shareholders Do Not Need to Take Action at This Time

Kennedy Lewis Investment Management LLC Announces Offer to Acquire Rapid Micro Biosystems

NEW YORK , June 30, 2022 /PRNewswire/ -- Kennedy Lewis Investment Management LLC today sent the following letter to the Board of Directors of Rapid Micro Biosystems, Inc. (NASDAQ: RPID): To the Board of...

Rapid Micro Biosystems Reports First Quarter 2022 Financial Results

Reports first quarter 2022 commercial revenue of $4.2 million

Rapid Micro Biosystems to Announce First Quarter 2022 Financial Results on May 10, 2022

LOWELL, Mass., April 26, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation soluti...

Wall Street Analysts Think Rapid Micro Biosystems, Inc. (RPID) Could Surge 310%: Read This Before Placing a Bet

The mean of analysts' price targets for Rapid Micro Biosystems, Inc. (RPID) points to a 309.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agre...

Does Rapid Micro Biosystems, Inc. (RPID) Have the Potential to Rally 215% as Wall Street Analysts Expect?

The consensus price target hints at a 214.9% upside potential for Rapid Micro Biosystems, Inc. (RPID). While empirical research shows that this sought-after metric is hardly effective, an upward trend i...

Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2021 Financial Results and Reaffirms Full Year 2022 Guidance

Reports fourth quarter 2021 total revenue of $5.2 million and commercial revenue of $4.9 million

Rapid Micro Biosystems to Participate at the Cowen 42nd Annual Health Care Conference

LOWELL, Mass., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutio...

Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2021 Financial Results on March 4, 2022

LOWELL, Mass., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Rapid Micro” or the “Company”), an innovative life sciences technology company providing mission critical a...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rapid Micro Biosystems, Inc. - RPID

New York, New York--(Newsfile Corp. - February 2, 2022) - Pomerantz LLP is investigating claims on behalf of investors of Rapid Micro Biosystems, Inc. ("Rapid Micro" or the "Company") (NASDAQ: RPID). Su...

Rapid Micro Biosystems Appoints Michael Beaulieu as Vice President, Investor Relations and Corporate Communications

LOWELL, Mass., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutio...

Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Revenue and Provides 2022 Re...

Full year 2021 commercial revenue expected to be between $21.3 million and $21.7 million

Rapid Micro Biosystems Announces Appointment of Inese Lowenstein to Board of Directors

LOWELL, Mass., Dec. 23, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutio...

Rapid Micro Biosystems Reports Third Quarter 2021 Financial Results

Reports third quarter 2021 total revenue of $6.9 million and commercial revenue of $6.3 million

Rapid Micro Biosystems to Present at Stifel 2021 Virtual Healthcare Conference

LOWELL, Mass., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Rapid Micro” or the “Company”), an innovative life sciences technology company providing mission critical a...

Rapid Micro to Announce Third Quarter 2021 Financial Results on November 11, 2021

Conference Call to Discuss Results on November 12, 2021 at 5:00am Pacific Time/8:00am Eastern Time Conference Call to Discuss Results on November 12, 2021 at 5:00am Pacific Time/8:00am Eastern Time

Rapid Micro Biosystems Announces Appointment of Andy Keys as Chief Commercial Officer

LOWELL, Mass., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (Rapid Micro), an innovative life sciences technology company providing mission critical automation solutions...

Rapid Micro Biosystems to Exhibit at the 2021 PDA Pharmaceutical Microbiology Conference on October 4-6

LOWELL, Mass., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Rapid Micro”), an innovative life sciences technology company providing mission critical automation soluti...

Rapid Micro Biosystems Reports Second Quarter 2021 Financial Results and Provides Business Update and Full Year 2021 ...

Reports second quarter 2021 commercial revenue of $5.7 million, representing 135% year-over-year growth

Rapid Micro Biosystems to Announce Second Quarter 2021 Financial Results on August 26, 2021

LOWELL, Mass., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutio...

Rapid Micro Biosystems Announces Exercise and Closing of Over-Allotment Option in Initial Public Offering

LOWELL, Mass., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Rapid Micro”), an innovative life sciences technology company providing mission critical automation solutio...